Invention Grant
- Patent Title: SSAO inhibitor
-
Application No.: US16714690Application Date: 2019-12-14
-
Publication No.: US11001563B2Publication Date: 2021-05-11
- Inventor: Zhi Luo , Xiaolin Li , Yaxun Yang , Lele Yang , Peng Li , Haiying He , Jian Li , Shuhui Chen
- Applicant: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
- Applicant Address: CN Heze
- Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
- Current Assignee: SHANDONG DANHONG PHARMACEUTICAL CO., LTD.
- Current Assignee Address: CN Heze
- Agency: W&K IP
- Priority: CN201710470167.8 20170620,CN201710661017.5 20170804,CN201711229457.X 20171129,CN201810582595.4 20180607
- Main IPC: C07D271/10
- IPC: C07D271/10 ; A61P1/16 ; C07D231/12 ; C07D235/18 ; C07D239/08 ; C07D239/26 ; C07D249/08 ; C07D257/04 ; C07D261/08 ; C07D261/20 ; C07D263/57 ; C07D271/06 ; C07D277/24 ; C07D405/04 ; C07D413/04 ; C07D417/04
Abstract:
The present invention provides an SSAO inhibitor and an application thereof in preparing a drug for treating a disease related to SSAO. In particular, the present invention provides a compound shown in formula (IV) and a pharmaceutically acceptable salt thereof.
Information query
